ijms-logo

Journal Browser

Journal Browser

Arthritis: Focus on Pathologies, Symptoms and Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 December 2025 | Viewed by 953

Special Issue Editor


E-Mail Website
Guest Editor
Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská Cesta 5826/9, SK-841 41 Bratislava, Slovakia
Interests: natural products; pharmacology; immunology; rheumatoid arthritis; medicinal plants; antioxidants; biological models; new generations of drug delivery; functional food
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Rheumatoid arthritis (RA) is a chronic, complex, immunopathogenetically mediated autoimmune disease that leads to severe destructive arthritis, affecting multiple joints with subsequent significant functional impairment, reducing the patient's quality of life, and potentially leading to disability. RA is characterized by chronic local and systemic inflammatory processes. It involves persistent synovitis with subsequent joint destruction, erosion, and deformation. Besides joint manifestations, extra-articular manifestations of the disease are not uncommon. After the onset of extra-articular symptoms, active investigation is always necessary, as they can significantly worsen the prognosis of the disease, including the patient's lifespan. Extraarticular manifestations of RA may develop during the clinical course of RA, even before the onset of arthritis. The onset of clinically evident RA is preceded by a period of preclinical RA (pre-RA). The development of pre-RA and its progression to established RA has been categorized into several different pathophysiological phases. The cause of RA is not yet fully understood. Genetic, environmental, hormonal, metabolic, immunological, and infectious factors may play a significant role. Advanced research techniques have enabled better characterization of cellular and molecular processes involved in the dysregulation of innate and acquired immune responses, with the identification of new pathways that are useful for the development of new therapeutic approaches for RA.

This Special Issue entitled Arthritis: Pathologies, Symptoms and Therapy welcomes manuscripts in the formats of research articles, short communications, case reports, and reviews. Manuscripts should focus on the research of ethiopatology of RA, its early and effective diagnosis based on well-defined symptoms and particularly on new therapeutic approaches of this serious diseases.

Dr. Katarína Bauerová
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rheumatoid arthritis
  • autoimmune
  • pathogenesis
  • strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

41 pages, 1127 KiB  
Review
Advances in Regenerative Therapies for Inflammatory Arthritis: Exploring the Potential of Mesenchymal Stem Cells and Extracellular Vesicles
by Timofey O. Klyucherev, Maria A. Peshkova, Maria D. Yurkanova, Nastasia V. Kosheleva, Andrey A. Svistunov, Xing-Jie Liang and Peter S. Timashev
Int. J. Mol. Sci. 2025, 26(12), 5766; https://doi.org/10.3390/ijms26125766 - 16 Jun 2025
Viewed by 744
Abstract
Inflammatory arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA), is a group of degenerative joint diseases that result in reduced mobility and a prevalent cause of disability. Despite differing etiologies, both conditions involve inflammation, affecting only the joints in OA and systemic in [...] Read more.
Inflammatory arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA), is a group of degenerative joint diseases that result in reduced mobility and a prevalent cause of disability. Despite differing etiologies, both conditions involve inflammation, affecting only the joints in OA and systemic in RA due to its autoimmune nature. Regenerative medicine offers promising alternatives, with a focus on the therapy with mesenchymal stem cell (MSC) and their secreted extracellular vesicles (EVs). MSC-derived EVs have shown great potential in modulating inflammatory pathways and promoting tissue repair in the preclinical models of RA and OA. Additionally, EVs from immune cells exhibit strong anti-inflammatory effects, reducing cartilage and bone degeneration. This review highlights the recent progress in MSC-based and EV-based therapies for OA and RA, discussing the bioengineering approaches that enhance the therapeutic efficacy, stability, and targeting of EV. It also addresses the major challenges in translating EV therapy from the laboratory to clinical practice and discusses strategies to overcome these obstacles in the treatment of inflammatory arthritis. Full article
(This article belongs to the Special Issue Arthritis: Focus on Pathologies, Symptoms and Therapy)
Show Figures

Figure 1

Back to TopTop